Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D0S2LQ
|
||||
Former ID |
DCL000940
|
||||
Drug Name |
PYY3-36
|
||||
Company |
Nastech; Merck
|
||||
Target and Pathway | |||||
Target(s) | Neuropeptide Y receptor type 2 | Target Info | Agonist | [536122] | |
KEGG Pathway | Neuroactive ligand-receptor interaction | ||||
References | |||||
Ref 536372 | Emerging drugs for acute and chronic heart failure: current and future developments. Expert Opin Emerg Drugs. 2007 Mar;12(1):75-95. | ||||
Ref 538947 | (http://www.guidetopharmacology.org/) Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 1554). |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.